Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.
read more
Source: NY Times
09:00, April 10, 2023
Christina Jewett and Pam Belluck
What Next for Banks?
15:13, April 10, 2023
Andrew Ross Sorkin, Ravi Mattu, Bernhard Warner, Sarah Kessler, Michael J. de la Merced, Lauren Hirsch and Ephrat Livni